肺结核患者的总补体活性（CH50）、补体C2和C3水平——一项初步研究 - Suppr | 超能文献

CH50, C'2 and C'3 levels in patients of tuberculosis--a preliminary study.

作者信息

Ganguly N K, Arya D, Chitkara N L, Malik S K

出版信息

Indian J Pathol Microbiol. 1977 Oct;20(4):243-9.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

CH50, C'2 and C'3 levels in patients of tuberculosis--a preliminary study.肺结核患者的总补体活性（CH50）、补体C2和C3水平——一项初步研究

Indian J Pathol Microbiol. 1977 Oct;20(4):243-9.

2

Normal levels of C2 and C'3 (B1C) by haemolytic and immunoadhesion method in healthy Indian subjects at Chandigarh.在昌迪加尔的健康印度受试者中，通过溶血法和免疫黏附法检测的C2和C'3（B1C）正常水平。

Indian J Med Res. 1976 Sep;64(9):1328-34.

3

[Study of the mechanism of the fall in complement levels in the synovial fluid in rheumatoid arthritis. I. Variations in the levels of C'1, C'4, C'2 and C'3 and total complement].类风湿关节炎滑液中补体水平下降机制的研究。I. C'1、C'4、C'2和C'3水平及总补体的变化

Pathol Biol (Paris). 1970 Nov;18(21):959-67.

4

Serum CH50 and C'3 levels in malaria.疟疾患者血清总补体活性（CH50）及补体C3水平

Indian J Med Res. 1982 Jul;76:130-3.

5

Complement as a mediator of inflammation. 3. Purification of the activity with anaphylatoxin properties generated by interaction of the first four components of complement and its identification as a cleavage product of C'3.补体作为炎症介质。3. 具有过敏毒素特性的活性物质的纯化，该活性物质由补体前四种成分相互作用产生，并鉴定为C'3的裂解产物。

J Exp Med. 1967 Dec 1;126(6):1027-48. doi: 10.1084/jem.126.6.1027.

6

[Determination of the total complement activity of serum and of 4 fractions: C'1, C'2, C'3, C'4].[血清总补体活性及4个组分（C'1、C'2、C'3、C'4）的测定]

Rev Fr Etud Clin Biol. 1967 Dec;12(10):1024-8.

7

[Determination of the fractions of complement (C'1, C'2, C'3, C'4) in hypocomplimentary glomerulopathies].[低补体性肾小球病中补体各成分（C'1、C'2、C'3、C'4）分数的测定]

Rev Fr Etud Clin Biol. 1967 Dec;12(10):990-5.

8

The second component of human complement: its isolation, fragmentation by C'1 esterase, and incorporation into C'3 convertase.人补体的第二个成分：其分离、被C'1酯酶裂解以及并入C'3转化酶。

J Exp Med. 1968 Sep 1;128(3):533-51. doi: 10.1084/jem.128.3.533.

9

Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement.源自人补体第二和第四成分的分子复合物的形成及其功能意义。

J Exp Med. 1967 Feb 1;125(2):359-80. doi: 10.1084/jem.125.2.359.

10

[Complement C'3 "Fraction in primary glomerulonephritis"].[原发性肾小球肾炎中的补体C'3成分]

Rev Clin Esp. 1975 Jun 15;137(5):397-405-.